Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Fish and Richardson
McKinsey
Accenture
Cantor Fitzgerald
Moodys
Queensland Health
Express Scripts
Cerilliant

Generated: July 16, 2018

DrugPatentWatch Database Preview

Diatrizoate meglumine; iodipamide meglumine - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for diatrizoate meglumine; iodipamide meglumine and what is the scope of diatrizoate meglumine; iodipamide meglumine freedom to operate?

Diatrizoate meglumine; iodipamide meglumine
is the generic ingredient in one branded drug marketed by Bracco and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for diatrizoate meglumine; iodipamide meglumine.
Summary for diatrizoate meglumine; iodipamide meglumine
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 9
DailyMed Link:diatrizoate meglumine; iodipamide meglumine at DailyMed

US Patents and Regulatory Information for diatrizoate meglumine; iodipamide meglumine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco SINOGRAFIN diatrizoate meglumine; iodipamide meglumine SOLUTION;INTRAUTERINE 011324-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Merck
Boehringer Ingelheim
Johnson and Johnson
Dow
Baxter
McKinsey
QuintilesIMS
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.